SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Value Creation Plan Crystallises

7 Jan 2013 07:00

RNS Number : 9097U
Gooch & Housego PLC
07 January 2013
 



For immediate release

7 January 2013

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Value Creation Plan Crystallises

 

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, announces that the Company's Value Creation Plan (VCP) crystallises today.

 

Further to the update issued on 4 October 2012, we are now able to provide details of the share option awards and share awards that will be made today. As a reminder, on 7 January 2010, following consultation with major shareholders, a share-based incentive scheme in the form of a VCP was put in place. At the same time approved share options were awarded under the Company Share Option Plan (CSOP) to UK-based participants. In accordance with the rules of the plan, on the third anniversary of the plan (today) the value created during the life of the plan, over and above a pre-determined threshold value based on a share price of £2.00, has been calculated and a share of that value (approximately 12%) will be distributed among the participating members of the senior management of the Company in the form of nil-cost share options (UK participants) and share awards (US participants). Half of the awards made today are exercisable immediately and the balance after twelve months, subject to certain conditions.

 

Details of the awards are as follows: -

 

Total number of market value CSOP share options awarded: 158,936

Total number of nil-cost share options and shares awarded: 1,380,566

 

In terms of dilutive effect, in aggregate these awards amount to 7% of the current issued share capital, although, as mentioned above, half the awards are not exercisable for twelve months.

 

Aggregate awards made to directors of the Company are as follows: -

 

Gareth Jones (CEO): 19,867 CSOP share options

450,747 Nil-cost share options

 

Terry Scribbins (COO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Andrew Boteler (CFO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Save for possibly some of the CSOP share options, the above directors are not planning to exercise any of their nil-cost options until June 2013 at the earliest.

 

For further information contact: -

 

Gareth Jones / Andrew Boteler

Gooch & Housego plc

01460 256440

Tim Thompson / Nicola Cronk

Buchanan

020 7466 5000

Patrick Robb/James Grace

Investec Bank plc

020 7597 5970

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNVUROAAARAR
Date   Source Headline
3rd Jun 20267:00 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim Results
20th May 20267:00 amRNSNotice of Half Year Results
10th Apr 20262:25 pmRNSHolding(s) in Company
9th Apr 20267:00 amRNSHalf Year Trading Update
20th Mar 20263:16 pmRNSHolding(s) in Company
27th Feb 20262:23 pmRNSResult of AGM
27th Feb 20267:00 amRNSAGM Trading Update
2nd Feb 20267:00 amRNSChief Financial Officer appointment date
22nd Jan 20262:26 pmRNSHolding(s) in Company
13th Jan 20264:41 pmRNSHolding(s) in Company
12th Jan 20264:34 pmRNSPDMR notice
12th Jan 20263:30 pmRNSGrant of LTIP awards
9th Jan 20267:00 amRNSPDMR Notice and Issue of Equity
7th Jan 20267:00 amRNSPosting of Annual Report and Notice of AGM
12th Dec 20257:00 amRNSAppointment of Chief Financial Officer
2nd Dec 202511:36 amRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSResults for the year ended 30 September 2025
25th Nov 20257:00 amRNSNotification of Full Year Results
20th Nov 20252:14 pmRNSHolding(s) in Company
4th Nov 20257:07 amRNSDirectorate Update
8th Oct 20257:00 amRNSFurther Issue of Shares and TVR
7th Oct 20257:00 amRNSFull Year Trading Update
1st Oct 20252:15 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSChief Financial Officer Transition
15th Jul 20255:08 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSNotification of Major Holdings
23rd Jun 20252:30 pmRNSHolding(s) in Company - Replacement
20th Jun 202512:08 pmRNSHolding(s) in Company
18th Jun 20257:00 amRNSCompletion of Acquisition & Total Voting Rights
3rd Jun 20257:00 amRNSInterim Results
20th May 20257:00 amRNSNotification of Half Year Results
14th May 20257:00 amRNSAcquisition of Global Photonics
9th Apr 20252:16 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSHalf Year Trading Update
24th Feb 20252:19 pmRNSResult of AGM
24th Feb 20257:00 amRNSAGM Trading Update
7th Jan 20252:58 pmRNSGrant of LTIP Awards
6th Jan 202511:15 amRNSPosting of Annual Report and Notice of AGM
20th Dec 20243:15 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSResults for the year ended 30 September 2024
4th Nov 20247:00 amRNSNotification of Full Year Results
30th Oct 20247:00 amRNSAcquisition of Phoenix Optical
28th Oct 20242:35 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSFull Year Trading Update
26th Sep 202410:31 amRNSDirector/PDMR Shareholding
23rd Aug 202412:52 pmRNSNotification of Major Holdings
16th Aug 20245:46 pmRNSHolding(s) in Company
16th Aug 20244:49 pmRNSHolding(s) in Company
15th Aug 20244:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.